Skip to search formSkip to main contentSkip to account menu

Dysfibrinogenemia

Known as: Dysfibrinogenaemia, dysfibrinogenemias 
Qualitatively abnormal fibrinogen. [DDD:akelly]
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Afibrinogenemia
Congenital hypofibrinogenemia

Narrower (1)

Dysfibrinogenemia, Congenital

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids).
Fibrinogen Cedar Rapids is a heterozygous dysfibrinogenemia (gammaR275C) that was associated with thromboembolism during and… 
1988
1988
A Monoclonal Antibody-Based Qunatitative Enzyme Immunoassay for the Determination of Plasma Fibrinogen Concentartions
Summary The most commonly used fibrinogen assays in the clinic are clotting rate assays, e.g. the Clauss method. Such functional… 
Highly Cited
1985
Highly Cited
1985
Congenital afibrinogenemia and recurrent early abortion: a case report.
Highly Cited
1983
Highly Cited
1983
Hereditary dysfibrinogenemia in a patient with thrombotic disease
A new case of congenital dysfibrinogenemia, in which the patient has severe thrombotic disease, is reported. The abnormal… 
1983
1983
The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains
To further evaluate the role of sialic acid in the dysfibrinogenemia associated with liver disease, we studied the effect of… 
1978
1978
Separation of both the Bbeta- and the gamma-polypeptide chains of human fibrinogen into two main types which differ in sialic acid content.
Highly Cited
1977
Highly Cited
1977
Acquired Dysfibrinogenaemia in Acute and Chronic Liver Disease
Plasma from patients with both acute and chronic liver disease has been examined for evidence of acquired dysfibrinogenaemia… 
Highly Cited
1969
Highly Cited
1969
Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation.
Abstract In a female patient with hepatoma and a prolonged thrombin time, the coagulation defect was shown to be localized in the… 
1969
1969
Studies on Fibrin Monomer Aggregation in Congenital Dysfibrinogenaemia (Fibrinogen ‘Zürich’): Separation of a Pathological from a Normal Fibrin Fraction
Further characterization of the delay in aggregation of fibrinogen ‘Zürich’ showed a potentiation of the defect by increasing… 
1966
1966
Familial Disturbance of Fibrin Monomer Aggregation
The investigation of the cause of an accidentally observed prolonged prothrombin time in a patient without a haemorrhagic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)